Verbena brasiliensis Vell.

https://thekeep.eiu.edu/herbarium_specimens_byname/19316/thumbnail.jp

Diversity and habitat differentiation of mosses and liverworts in the cloud forest of. Monteverde, Costa Rica

Ciento noventa especies de briofitas (133 hepáticas, 56 musgos, 1 antocerote) fueron encontradas en un inventario hecho en 4 hectáreas del sotobosque y el dosel en el bosque nublado (1500 m) de Monteverde, Costa Rica. Las ramas gruesas del dosel fueron la porción más rica en termino de numero de especies (99), en troncos había 65 especies, lianas, arbustos, árboles juveniles o hojas vivas en el sotobosque tenían entre 36-46 especies cada una, y 16 especies fueron encontradas en troncos en descomposición. Las cifras ilustran la gran diversidad de microhabitats de briofitas en el bosque nublado. Cerca de 36% de las especies, incluyendo mas de la mitad de los corticolos, se presentaron exclusivamente en el dosel. Parece que el porcentaje de especies de briofitas restringidas al dosel podría ser el mismo en bosques de tierras bajas y en bosques nublados, a pesar de la gran diferencia en abundancia y composición taxonómica de las briofitas en las dos clases de bosque.An inventory of the understory and canopy of 4 ha oflower montane cloud forest at Monteverde, Costa Rica, yielded 190 bryophyte species: 133 hepatics, 56 mosses and 1 homwort. Thick branches of the lower canopy were by far the richest habitat in terms of number of species (99), trunks from 1m upwards had 65 species, lianas, shrubs, saplings, or living leaves in the understory had about 36-46 species each, and 16 species were found on rotten logs. The figures are illustrative of the great diversification of microhabitats of bryophytes in a tropical montane cloud forest. About 36% ofthe species, including more than half ofthe corticolous ones, occurred exclusively in the canopy. It appeared thatthe percentage ofbryophyte species restricted to the canopy may be the same in lowland and montane rain forests, in spite of the great differences in species abundance and composition in the two kinds of forest

Catagonium politum

Bryophyte

Campylopus thysanomitrioides

Bryophyte

Campylopus trichophorus

Bryophyte

Verbena brasiliensis Vell.

https://thekeep.eiu.edu/herbarium_specimens_byname/19316/thumbnail.jp

Diversity and habitat differentiation of mosses and liverworts in the cloud forest of. Monteverde, Costa Rica

An inventory of the understory and canopy of 4 ha oflower montane cloud forest at Monteverde, Costa Rica, yielded 190 bryophyte species: 133 hepatics, 56 mosses and 1 homwort. Thick branches of the lower canopy were by far the richest habitat in terms of number of species (99), trunks from 1m upwards had 65 species, lianas, shrubs, saplings, or living leaves in the understory had about 36-46 species each, and 16 species were found on rotten logs. The figures are illustrative of the great diversification of microhabitats of bryophytes in a tropical montane cloud forest. About 36% ofthe species, including more than half ofthe corticolous ones, occurred exclusively in the canopy. It appeared thatthe percentage ofbryophyte species restricted to the canopy may be the same in lowland and montane rain forests, in spite of the great differences in species abundance and composition in the two kinds of forest.  Ciento noventa especies de briofitas (133 hepáticas, 56 musgos, 1 antocerote) fueron encontradas en un inventario hecho en 4 hectáreas del sotobosque y el dosel en el bosque nublado (1500 m) de Monteverde, Costa Rica. Las ramas gruesas del dosel fueron la porción más rica en termino de numero de especies (99), en troncos había 65 especies, lianas, arbustos, árboles juveniles o hojas vivas en el sotobosque tenían entre 36-46 especies cada una, y 16 especies fueron encontradas en troncos en descomposición. Las cifras ilustran la gran diversidad de microhabitats de briofitas en el bosque nublado. Cerca de 36% de las especies, incluyendo mas de la mitad de los corticolos, se presentaron exclusivamente en el dosel. Parece que el porcentaje de especies de briofitas restringidas al dosel podría ser el mismo en bosques de tierras bajas y en bosques nublados, a pesar de la gran diferencia en abundancia y composición taxonómica de las briofitas en las dos clases de bosque.</p

Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database

Background: The aim of this study was to describe data on epidemiology, ventilatory management, and outcome of acute respiratory distress syndrome (ARDS) in immunocompromised patients. Methods: We performed a post hoc analysis on the cohort of immunocompromised patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study. The LUNG SAFE study was an international, prospective study including hypoxemic patients in 459 ICUs from 50 countries across 5 continents. Results: Of 2813 patients with ARDS, 584 (20.8%) were immunocompromised, 38.9% of whom had an unspecified cause. Pneumonia, nonpulmonary sepsis, and noncardiogenic shock were their most common risk factors for ARDS. Hospital mortality was higher in immunocompromised than in immunocompetent patients (52.4% vs 36.2%; p &lt; 0.0001), despite similar severity of ARDS. Decisions regarding limiting life-sustaining measures were significantly more frequent in immunocompromised patients (27.1% vs 18.6%; p &lt; 0.0001). Use of noninvasive ventilation (NIV) as first-line treatment was higher in immunocompromised patients (20.9% vs 15.9%; p = 0.0048), and immunodeficiency remained independently associated with the use of NIV after adjustment for confounders. Forty-eight percent of the patients treated with NIV were intubated, and their mortality was not different from that of the patients invasively ventilated ab initio. Conclusions: Immunosuppression is frequent in patients with ARDS, and infections are the main risk factors for ARDS in these immunocompromised patients. Their management differs from that of immunocompetent patients, particularly the greater use of NIV as first-line ventilation strategy. Compared with immunocompetent subjects, they have higher mortality regardless of ARDS severity as well as a higher frequency of limitation of life-sustaining measures. Nonetheless, nearly half of these patients survive to hospital discharge. Trial registration: ClinicalTrials.gov, NCT02010073. Registered on 12 December 2013